Literature DB >> 19554259

Glucose binds to the insulin receptor affecting the mutual affinity of insulin and its receptor.

Robert Root-Bernstein1, Jessica Vonck.   

Abstract

Insulin activity is sensitive to glucose concentration but the mechanisms are still unclear. An unexamined possibility is that the insulin receptor (IR) is sensitive to glucose concentration. We demonstrate here that insulin-like peptides derived from the IR bind glucose at low millimolar, and cytochalasin B at low micromolar, concentrations; several insulin-like IR peptides bind insulin at nanomolar Kd; and this binding is antagonized by increasing glucose concentrations. In addition, glucose and cytochalasin B bind to IR isolated from rat liver and increasing glucose decreases insulin binding to this IR preparation. The presence of GLUT 1 in our IR preparation suggests the possibility of additional glucose-mediated allosteric control. We propose a model in which glucose binds to insulin, the IR, and GLUT; insulin binds to the IR; and the IR binds to GLUT. This set of interactions produces an integrated system of insulin-dependent interactions that is highly sensitive to glucose concentration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554259     DOI: 10.1007/s00018-009-0065-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  54 in total

1.  Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle.

Authors:  A C Boyd; Y H Abdel-Wahab; A M McKillop; H McNulty; C R Barnett; F P O'Harte; P R Flatt
Journal:  Biochim Biophys Acta       Date:  2000-09-01

Review 2.  FACTORS CONCERNED WITH INSULIN SYNTHESIS AND RELEASE.

Authors:  J B FIELD
Journal:  Metabolism       Date:  1964-05       Impact factor: 8.694

Review 3.  Peptide self-aggregation and peptide complementarity as bases for the evolution of peptide receptors: a review.

Authors:  Robert S Root-Bernstein
Journal:  J Mol Recognit       Date:  2005 Jan-Feb       Impact factor: 2.137

4.  Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture.

Authors:  Y H Abdel-Wahab; F P O'Harte; C R Barnett; P R Flatt
Journal:  J Endocrinol       Date:  1997-01       Impact factor: 4.286

5.  Molecular complementarity I: the complementarity theory of the origin and evolution of life.

Authors:  R S Root-Bernstein; P F Dillon
Journal:  J Theor Biol       Date:  1997-10-21       Impact factor: 2.691

6.  Insulin degradation by intact erythrocytes is associated with low-affinity insulin binding sites.

Authors:  A Marttinen
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

7.  Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin.

Authors:  F P O'Harte; A C Boyd; A M McKillop; Y H Abdel-Wahab; H McNulty; C R Barnett; J M Conlon; P Højrup; P R Flatt
Journal:  Peptides       Date:  2000-10       Impact factor: 3.750

8.  Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes. Chronic ability to increase glycogen synthase activity.

Authors:  F B Lima; S Bao; W T Garvey
Journal:  Diabetes       Date:  1994-01       Impact factor: 9.461

9.  Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.

Authors:  O Pedersen; E Hjøllund; H Beck-Nielsen; H O Lindskov; O Sonne; J Gliemann
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

10.  Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.

Authors:  K Suzuki; T Kono
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  11 in total

1.  Insulin facilitates corneal wound healing in the diabetic environment through the RTK-PI3K/Akt/mTOR axis in vitro.

Authors:  C Peterson; H L Chandler
Journal:  Mol Cell Endocrinol       Date:  2022-02-26       Impact factor: 4.369

Review 2.  Insulin Receptor Isoforms in Physiology and Disease: An Updated View.

Authors:  Antonino Belfiore; Roberta Malaguarnera; Veronica Vella; Michael C Lawrence; Laura Sciacca; Francesco Frasca; Andrea Morrione; Riccardo Vigneri
Journal:  Endocr Rev       Date:  2017-10-01       Impact factor: 19.871

3.  A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control.

Authors:  Vinay Bhaskar; Ira D Goldfine; Daniel H Bedinger; Angela Lau; Hua F Kuan; Lisa M Gross; Masahisa Handa; Betty A Maddux; Susan R Watson; Shirley Zhu; Ajay J Narasimha; Raphael Levy; Lynn Webster; Sujeewa D Wijesuriya; Naichi Liu; Xiaorong Wu; David Chemla-Vogel; Catarina Tran; Steve R Lee; Steve Wong; Diane Wilcock; Mark L White; John A Corbin
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

4.  Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs?

Authors:  Riccardo Vigneri; Sebastiano Squatrito; Lucia Frittitta
Journal:  Diabetes       Date:  2012-05       Impact factor: 9.461

5.  Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator.

Authors:  Margaret Wu; Ge Dai; Jun Yao; Scott Hoyt; Liangsu Wang; James Mu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.

Authors:  Richard J Naftalin
Journal:  F1000Res       Date:  2016-04-12

7.  Rapid Non-Enzymatic Glycation of the Insulin Receptor under Hyperglycemic Conditions Inhibits Insulin Binding In Vitro: Implications for Insulin Resistance.

Authors:  Tyler Rhinesmith; Thomas Turkette; Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2017-12-02       Impact factor: 5.923

8.  Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia.

Authors:  John A Corbin; Vinay Bhaskar; Ira D Goldfine; Hassan Issafras; Daniel H Bedinger; Angela Lau; Kristen Michelson; Lisa M Gross; Betty A Maddux; Hua F Kuan; Catarina Tran; Llewelyn Lao; Masahisa Handa; Susan R Watson; Ajay J Narasimha; Shirley Zhu; Raphael Levy; Lynn Webster; Sujeewa D Wijesuriya; Naichi Liu; Xiaorong Wu; David Chemla-Vogel; Steve R Lee; Steve Wong; Diane Wilcock; Paul Rubin; Mark L White
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

9.  Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.

Authors:  Robert Root-Bernstein; Abigail Podufaly; Patrick F Dillon
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-21       Impact factor: 5.555

Review 10.  Fortifying the Treatment of Prostate Cancer with Physical Activity.

Authors:  Colin E Champ; Lanie Francis; Rainer J Klement; Roger Dickerman; Ryan P Smith
Journal:  Prostate Cancer       Date:  2016-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.